Vincent Linder, PhD
As a Scientist and entrepreneur, I am interested in helping clients with the development of their innovative technologies and products, and accelerating time to market. During my career I have successfully led multiple phases of product development, spanning from invention at the bench to regulatory approvals. I help early stage companies/projects navigate through the many facets of the development of biomedical devices: expert in assay integration and optimization onto miniaturized devices (microfluidics), I work routinely and effectively at the interfaces of clinical, regulatory, quality, engineering, reimbursement and intellectual property.
I am the Co-inventor of a suite of point-of-care technologies and co-founder of Claros Diagnostics, and was its Chief Technology Officer for 14 years, leading the company to its first FDA Pre-Market Approval. I did my post-doc at Harvard University after obtaining a Ph.D. in clinical pharmacology (Insel University Hospital), microtechnology (Institute of Microtechnology, Neuchâtel), and biosensor (CSEM), and a M.Sc. in Chemistry (University of Neuchâtel). I am co-author of more than 300 issued/pending patents and 25 peer-reviewed publications in leading journals, including medical and health economics publications.
From my current European location, and in collaboration with the Popper team, I am well positioned to help European companies expand into the US market and vice versa.